CommentaryIs there a role for tetrathiomolybdate in the treatment of primary biliary cirrhosis?
References (29)
- et al.
Primary biliary cirrhosis
Lancet
(2003) Ludwig symposium on biliary disorders—part II. Pathologic features and evolution of primary biliary cirrhosis and primary sclerosing cholangitis
Mayo Clin Proc
(1998)- et al.
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis
Gastroenterology
(1994) - et al.
Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis
Gastroenterology
(1996) - et al.
Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis
Gastroenterology
(1997) - et al.
Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid
Gastroenterology
(2006) - et al.
Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid
Gastroenterology
(2009) - et al.
The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis
Gastroenterology
(2005) - et al.
D-penicillamine treatment improves survival in primary biliary cirrhosis
Lancet
(1981) - Askari F, Innis D, Dick R, et al. Treatment of primary biliary cirrhosis with tetrathiomolybdate: results of a double...
Primary biliary cirrhosis
N Engl J Med
(2005)
Primary biliary cirrhosis
Hepatology
(2009)
Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid
Liver
(1999)
Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis
Hepatology
(2008)
Cited by (0)
Copyright © 2010 Mosby, Inc. All rights reserved.